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Cystatin C (Cys C) has been shown to be an alternative
marker of renal function. However, estimation of the
glomerular filtration rate (GFR) based on Cys C has received
little attention. Recently, several Cys C-based equations were
developed in different patient cohorts. To date, the benefit of
a Cys C-based GFR calculation in patients after renal
transplantation (RTx) remains to be elucidated. We compared
the diagnostic accuracy of three Cys C-based formulae
(Larsson, Hoek, Filler which used an immunonephelometric
method) with the results of the Modification of Diet in Renal
Disease (MDRD) formula. GFR was measured by means
of technetium-diethylenetriamine pentaacetic acid
(99mTc-DTPA) clearance in 108 consecutive patients after RTx.
Correlation coefficients of all calculated GFR estimates with
the true GFR were high but did not differ significantly from
one another (0.83–0.87). The MDRD and Filler equations
overestimated GFR significantly, whereas the Larsson
equation significantly underestimated GFR. Bias of the Hoek
formula was negligible. Precision of the Hoek (8.9 ml/min/
1.73 m2) and Larsson equations (9.6 ml/min/1.73 m2) were
significantly better than MDRD equations (11.4 ml/min/
1.73 m2; Pp0.035 each). Accuracy within 30% of real GFR was
67.0 and 65.1% for the MDRD and Filler formulae, and 77.1%
for the Larsson and Hoek formulae, respectively. Accuracy
within 50% of true GFR for the Hoek formula (97.2%) was
better than for the MDRD equations (85.3%). Cys C-based
formulae may provide a better diagnostic performance than
creatinine-based equations in GFR calculation after RTx.
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After kidney transplantation the glomerular filtration rate
(GFR) is considered to be the best index for monitoring graft
function. Renal clearance of exogenous markers, such as
inulin, technetium-diethylenetriamine pentaacetic acid
(99mTc-DTPA), 51Cr–EDTA, and 125I-Iothalamate are ac-
cepted as the best measure to determine GFR. However, such
procedures are invasive, time consuming, expensive and
hence not ideal for clinical practice or large-volume clinical
research.
Therefore, GFR calculation is recommended.1 Unfortu-
nately, the most commonly used Cockroft and Gault formula
(C&G) as well as several other equations have been reported
to be inaccurate in patients after renal transplantation
(RTx).2,3 As a consequence, interest has arisen in alternative
endogenous markers of renal function. In a recent meta
analysis, cystatin C (Cys C), a 13.3-kDa protein, was
evaluated in patients with various renal diseases and found
to be superior to creatinine.4 In patients after RTx, Cys C
performs at least as well as creatinine as a kidney function
marker.5–7
Recently, three formulae using Cys C serum levels instead
of creatinine as an endogenous marker were suggested for
calculation of GFR in adult patients as well as in children
with various renal diseases.
In all three formulae, the identical immunonephelometric
Cys C method on a Dade Behring nephelometer was applied.
We evaluated these three formulae in comparison to the
simplified Modification of Diet in Renal Disease (MDRD)
formula8 in an unselected consecutive cohort of renal
transplant recipients who had their GFR determined by a
gold standard method.
RESULTS
In this cohort, the mean creatinine concentration was 159
(95% confidence interval (CI) 144–174) mmol/l. The mean
Cys C concentration was 2.24 (95% CI 2.03–2.45) mg/l.
Mean GFR measured by 99mTc-DTPA was 39.5 (95% CI
36.4–42.6) ml/min/1.73 m2. GFR estimates based on the
MDRD, Larsson and Filler equations differed significantly
from 99mTc-DTPA clearance (Po0.001 for all). In contrast,
results from the Hoek formula did not differ from true GFR
(P¼ 0.5). All tests describing GFR correlated well with the
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measures of the 99mTc-DTPA clearance (Po0.0001 for all).
No significant differences in correlation coefficients were
found between the applied equations (see Table 1).
A mean overestimation of 7.92 (95% CI 5.73–10.1) and
6.72 (95% CI 4.62–8.82) ml/min/1.73 m2 was found for the
MDRD and Filler equations, respectively. In contrast, the
Larsson formula underestimated the true GFR by 3.20 (95%
CI 5.03 1.36) ml/min/1.73 m2. Furthermore, the results of
the Hoek formula were very similar to the true GFR 0.58
(95% CI 2.29 1.14) ml/min/1.73 m2. The mean difference
of the estimates derived from the Hoek formula and the true
GFR was significantly lower than the results of all other
formulae (Po0.0001 for all). The bias of the Larsson equation
was significantly different from the MDRD and the Filler
equation (Po0.0001 for both). Bias of the MDRD equation
did not differ significantly from the Filler equation (P¼ 0.29).
Root mean square error (RMSE) was used as a measure of
precision: the higher the RMSE the lower the precision. The
MDRD formula (11.43 ml/min/1.73 m2) was significantly
worse compared to the Larsson GFR (9.59 ml/min/1.73 m2,
P¼ 0.035; F-statistics: 1.4205) and the Hoek GFR (8.94 ml/
min/1.73 m2, P¼ 0.006; F-statistics: 1.6346). No differences
were found between precision of the Filler (10.95 ml/min/
1.73 m2) and the MDRD formula (P¼ 0.33).
F-statistics showed no differences between the Hoek and
Larsson GFR (P¼ 0.23) and between Filler and Larsson
equation (P¼ 0.09). However, Hoek formula was more precise
than the Filler equation (P¼ 0.019; F-statistics: 1.5002).
As suggested by clinical practical guidelines of the
National Kidney Foundation, the analysis of a new GFR
equation should include the proportion of the GFR estimates
which are within 30 and 50% of measured GFR. Additionally,
we provide the data for a 10% cutoff to test whether Cys C-
based equations can sufficiently replace gold standard
measurements.9 Results are given in Figure 1.
When we compared the 95% CI of the different equations
we found that the 95% CI of the Hoek and MDRD equation
did not overlap for the 50% accuracy indicating a significant
higher accuracy of the Hoek equation.
Bland and Altman plots, a graphical method to demon-
strate the magnitude and consistency of the differences
between calculated and measured values, are presented in
Figure 2a–d.
The graphical technique demonstrates the span between
þ 1.96 s.d. and 1.96 s.d. of the mean difference between the
calculated and the true GFR.
The limits of agreement estimated for the Hoek equation
are 18 ml/min/1.73 m2 below or 17 ml/min/1.73 m2 above the
true GFR. Similarly, the Larsson equation showed a span
between 22 and 16 ml/min/1.73 m2. Comparing the range
between the limits of agreement of the Hoek and the Larsson
formula (35 and 38 ml/min/1.73 m2, respectively) with the
MDRD, we found a considerably higher distance between
both limits for the MDRD estimates (45 ml/min/1.73 m2)
(Table 2).
Two further questions were aimed in our analysis: First, to
identify the impact of higher steroid dosages on the
performance of Cys C-based equations. Second, we analyzed
the diagnostic performance of the Cys C-based formulae in
patients with CKD stages 4 and 5 since numbers of patients
with chronic renal allograft nephropathy and long-term
survival after transplantation increase. In the first analysis, we
compared a subgroup of patients with 10 mg or more
prednisone per day (n¼ 14, group A) with the majority of
our patients who received 5 mg or less prednisone per day
(n¼ 87, group B) (Table 3).
Both Cys C-based GFR estimations which showed results
similar to GFR in group B were found to considerably
underestimate true GFR in group A. The Filler equation
overestimated GFR in the low-dose group, but did not differ
Table 1 | Statistical data from the different GFR estimates
Median
estimates
(ml/min/
1.73 m2)
Range (ml/
min/1.73 m2)
Correlation
coefficient (r)
Median
difference
(ml/min/
1.73 m2)
Median
absolute
difference
(ml/min/
1.73 m2)
Median %
difference
(%)
10% (95% CI)
(%)
Accuracy
within 30%
(95% CI) (%)
50% (95% CI)
(%)
DTPA 37.0 11.8–82.9
MDRD 46.2 10.0–115 0.832 +6.75 7.90 +20.3 24.8 (17.6–33.7) 67.0 (57.7–75.1) 85.3 (77.4–90.9)
Larsson 33.2 7.78–104 0.859 4.78 6.00 14.7 20.2 (13.7–28.8) 77.1 (68.3–84.0) 95.4 (89.5–98.3)
Hoek 36.9 8.72–97.4 0.865 1.50 7.40 4.40 33.0 (24.9–42.4) 77.1 (68.3–84.0) 97.2 (91.9–99.4)
Filler 43.3 11.9–119 0.863 +3.95 6.30 +12.4 28.4 (20.8–37.6) 65.1 (55.8–73.5) 87.2 (79.5–92.3)
(95% CI)=95% confidence interval; DTPA: diethylenetriamine pentaacetic acid; MDRD: Modification of Diet in Renal Disease formula; GFR: glomerular filtration rate.
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Figure 1 | Accuracy of different GFR estimates expressed as the
percentage of estimates within 10, 30, and 50% of the true GFR.
Highest accuracy was found for the Hoek equation.
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from true GFR in the subgroup of patients with 10 mg
or more prednisone per day. The differences in bias were
significant between groups A and B for all Cys C-based GFR
estimations (Po0.015). Moreover, the precision of the Filler
equation was significantly better in the ‘high’ prednisone dose
group (P¼ 0.028; F-statistics: 2.612).
On the contrary, in the ‘low’-dose group, the accuracy
within 50% of true GFR showed no overlap of the 95% CI
when Hoek equation was compared with the MDRD and
the Filler formulae. However, the Larsson formula showed
a small overlap of the 95% CI with the MDRD and Filler
equation. At the accuracy within 30 and 10% of true GFR,
none of the Cys C-based GFR equations was significantly
superior to the MDRD formula.
In the second subanalysis, we investigated the performance
of the equations in 33 patients with a true GFR below 30 ml/
min/1.73 m2 (Table 4). We expected a better performance of
the MDRD equation due to exponential increase of creatinine
when GFR falls below 30 ml/min/1.73 m2. However, Larsson
and Hoek formulae were slightly better than MDRD with
regard to correlation, bias, precision, and accuracy (n.s.).
DISCUSSION
In this study, the diagnostic performance of four methods of
GFR estimation was tested against the gold standard-derived
GFR. A combination of different statistical analyses was used
to evaluate their particular performance in patients after
kidney transplantation. We demonstrate that the diagnostic
performance of Cys C-based formulas that are easy to
perform are more accurate than or at least equal to the four
different variables containing MDRD formula.
It is well known that serum creatinine concentrations
are influenced by muscle mass, dietary protein intake, sex
and age,10 thus limiting the precision of creatinine-based
methods. Furthermore, in patients with reduced GFR,
tubular secretion of creatinine increases.11 Consequently,
creatinine-based GFR estimates like the Cockroft and Gault
equation overestimate true GFR.12
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Figure 2 | Bland and Altman analysis of GFR estimates in 108 patients. In this analysis, the differences between two methods are plotted
against the true GFR for each individual patient. The mean difference is indicated by the line, limits of agreement are indicated by the
dotted lines. (a) Shows the results for the Hoek equation and the GFR, (b) the results for the Larsson equation are given, (c) for the Filler
equation, and (d) for the MDRD equation in, respectively. Data are given in ml/min/1.73 m2.
Table 2 | Limits of agreement of GFR estimates
Lower limit (95% CI)
(ml/min/1.73 m2)
Upper limit (95% CI)
(ml/min/1.73 m2)
MDRD 14.6 (16.8–12.4) 30.4 (28.2–32.6)
Larsson 22.1 (23.9–20.2) 15.7 (13.8–17.5)
Hoek 18.2 (19.9–16.5) 17.0 (15.3–18.7)
Filler 14.8 (16.9–12.8) 28.3 (26.2–30.4)
(95% CI)=95% confidence interval; MDRD: Modification of Diet in Renal Disease
formula; GFR: glomerular filtration rate.
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The simplified MDRD formula is recommended by the
National Kidney Foundation to estimate GFR in cohorts
similar to the MDRD participants.13 However, in cohorts
dissimilar to the MDRD study group and especially in patients
after kidney transplantation, the diagnostic performance of
the MDRD formula was suboptimal indicating that gold
standard clearance may still be required.2 Despite the fact that
we recently suggested the so-called MDRD6 formula as the
best-performing GFR estimation in patients after kidney
transplantation14 we preferred the simplified MDRD as a
comparator for the Cys C-based equations in this study. This is
based on the fact that our promising results of the MDRD6
formula still warrant confirmation by other groups. Addition-
ally, several publications recently demonstrated in patients
after RTx that accuracy and precision of the simplified
MDRD formula are better than that of the Cockcroft–Gault
formula.2,3,14 Thus, the simplified MDRD formula seems to be
more suitable.
Even so, the question arises what may be better, the
MDRD6 equation or Cys C-based formulae. In our present
study the MDRD6 formula showed an accuracy within 50%
of true GFR of 89.5%, which was inferior to the Cys C-based
Larsson and Hoek formulae (data not shown).
Of the three tested Cys C-based equations the Filler
formula did not differ from MDRD estimates with respect to
correlation, bias, precision and accuracy.
Although the Filler formula was derived from a cohort
where the 99mTc-DTPA clearance was performed – similar to
our technique – using a single-injection technique and a
multiple point blood sampling method, the estimates differed
significantly from true GFR. Different patient characteristics
may account for these divergences: Fillers cohort comprised
children aged 1–18 years having a significant hyperfiltration
with a mean GFR above 100 ml/min/1.73 m2, which is more
than twice the mean GFR in our study. Despite the fact that
Cys C concentrations do not change after the first year of life,
it is not known whether the same Cys C value reflects the
same GFR over decades.
The Larsson formula had been evaluated in a cohort of
100 patients aged 4–92 years where GFR was determined by
iohexol clearance, showing a GFR of 10–115 ml/min/1.73 m2.
No control group was included since two commercially
available Cys C assays were compared.
In comparison to the Larsson formula, the Hoek equation
which was derived by linear regression showed a better
accuracy and precision.15 The 146 participants of the
Table 3 | Subanalysis of different GFR estimates for patients receiving different corticosteroid dosages
Median
estimates (ml/
min/1.73 m2)
Range (ml/
min/1.73 m2)
Correlation
coefficient (r)
Mean
difference
(ml/min/
1.73 m2)
RMSE (ml/
min/1.73 m2)
10% (95% CI)
(%)
Accuracy
within 30%
(95% CI) (%)
50% (95% CI)
(%)
Group A
DTPA 38.0 16.0–58.0
MDRD 43.8 16.7–74.2 0.816 6.84 8.57 14.3 (2.91–41.5) 57.1 (32.8–78.9) 71.4 (45.2–88.9)
Larsson 28.9 8.10–43.7 0.853 8.75 6.32 21.4 (7.01–48.6) 64.3 (38.8–84.0) 92.9 (66.8–99.9)
Hoek 32.6 9.20–46.7 0.860 5.66 6.29 35.7 (16.4–61.6) 42.9 (21.6–67.7) 64.3 (38.8–84.0)
Filler 38.2 12.3–55.2 0.857 0.05 6.92 14.3 (2.91–41.5) 50.0 (27.0–73.4) 71.4 (45.2–88.9)
Group B
DTPA 37.0 11.8–82.9
MDRD 48.0 10.0–115 0.831 8.18 12.0 26.4 (18.3–36.7) 63.2 (52.8–72.7) 85.1 (76.0–91.2)
Larsson 34.3 7.78–104 0.865 1.91 9.85 19.5 (12.5–29.2) 79.3 (69.6–86.6) 96.6 (90.0–99.3)
Hoek 38.0 8.72–97.4 0.871 0.59 9.13 32.2 (23.3–42.6) 78.2 (68.4–85.7) 97.7 (91.6–99.9)
Filler 44.6 11.9–119 0.868 8.28 11.2 27.6 (19.3–37.9) 58.6 (48.2–68.4) 83.9 (74.7–90.3)
(95% CI)=95% confidence interval; DTPA: diethylenetriamine pentaacetic acid; GFR: glomerular filtration rate; MDRD: Modification of Diet in Renal Disease formula; RMSE: root
mean square error.
Group A: patients with X10 mg prednisone per day (n=14).
Group B: patients with p5 mg prednisone per day (n=87).
Table 4 | Subanalysis of different GFR estimates for patients with DTPA-GFR o30 ml/min/1.73m2
Median
estimates (ml/
min/1.73 m2)
Range (ml/
min/1.73 m2)
Correlation
coefficient (r)
Mean
difference
(ml/min/
1.73 m2)
RMSE (ml/
min/1.73 m2)
10% (95% CI)
(%)
Accuracy
within 30%
(95% CI) (%)
50% (95% CI)
(%)
DTPA 21.0 11.8–29.8
MDRD 24.0 10.0–58.9 0.588 +4.40 7.61 27.3 (15.0–44.5) 57.6 (40.9–72.9) 81.8 (65.4–91.9)
Larsson 18.8 7.78–43.7 0.698 1.95 6.10 18.2 (8.32–34.9) 66.7 (49.6–80.4) 90.9 (75.8–97.7)
Hoek 21.9 8.72–46.9 0.704 +0.86 6.62 33.3 (19.8–50.6) 63.6 (46.7–78.0) 90.9 (75.8–97.7)
Filler 26.0 11.9–55.2 0.702 +5.29 7.64 12.1 (4.29–28.1) 57.6 (40.9–72.9) 75.8 (58.9–87.5)
(95% CI)=95% confidence interval; DTPA: diethylenetriamine pentaacetic acid; MDRD: Modification of Diet in Renal Disease formula; RMSE: root mean square error.
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Hoek study differed from our cohort with respect to age,
heterogeneity of renal function and the underlying renal
diseases. Importantly, the Hoek study was the only one that
used a continuous infusion technique as the gold standard
method for GFR determination. This might be a possible
explanation for the fact that the Hoek formula is more
accurate and precise than the other formulae.
Despite the improved GFR estimation by the Hoek and
Larsson formulae it should be noted that an ideal GFR
equation as suggested by the National Kidney Foundation
ought to cover 99% of all tests within 10% of true GFR.9
Such an ambitious objective is highly recommended in
patients with renal grafts. However, from this point of view
all tested equations are far from being ideal. Yet, by time and
with increasing knowledge of Cys C-derived GFR equations
in RTx it may be possible to further improve the diagnostic
performance of these equations. Nonetheless, we must bear
in mind that currently, a gold standard clearance procedure
cannot be replaced by these estimates.
Continuous low-dose steroid medication, as performed in
our cohort, has been supposed to increase Cys C serum
levels.16 Based on this hypothesis, the possibly falsely elevated
Cys C level resulted in an underestimation of GFR, which has
recently been described in children.17 This steroid-induced
underestimation of GFR may be reflected by the negative
bias of the Hoek and Larsson formulae. Although data on
steroid effects remain inconsistent,18 we performed a sub-
analysis comparing patients differing in prednisone dosages.
Since the ‘low’-dose subgroup comprised the majority of
our cohort, these results did not differ from the entire
study population. On the contrary, the 14 patients receiving
10 mg or more prednisone per day showed a considerable
underestimation of GFR when Hoek and Larsson formulae
were used.
However, as our study was not designed to perform such
an analysis both subgroups had a different size and differed
also in mean time since transplantation (group A: 4.3 vs
group B: 91.1 months). Precision of the Filler formula was
best in the ‘high’ steroid dosage group, however, we ought to
keep in mind the small sample size. Therefore, these data
have to be interpreted with caution as our conclusion
warrants further confirmation by other investigators.
Besides corticosteroids immunosuppression with calci-
neurin inhibitors has also been proposed to influence Cys C
serum levels.7,19 Thus, we tested the hypothesis whether both
of the applied calcineurin inhibitors affect the performance of
the Cys C-based equations. However, neither bias, precision
nor accuracy were different in patients receiving cyclosporine
A or tacrolimus (data not shown).
Since creatinine increases exponentially when GFR drops
below 30 ml/min/1.73 m2, we performed a further subanalysis
in patients with advanced renal failure and tested the
diagnostic performance of the Cys C-based equations.
Although the MDRD equation performed somewhat better
than in the entire cohort, the Cys C-based Hoek and Larsson
formulae remained superior, although these differences did
not reach statistical significance. However, it should be
stressed, that the 33 patients may not be enough to detect
differences.
Most recently, White et al.20 investigated Cys C-based
equations in a cohort after kidney transplantation. In this
study, the accuracy of the Filler formula was superior to the
Hoek formula. Whereas in both studies, the Cys C-based
equations by Hoek and Filler showed a higher precision than
creatinine-based formulae, differences occurred with respect
to bias. Similar to our results, the Filler formula calculated
the highest GFR values of all tested Cys C-based equations.
However, in this cohort, the bias of the Filler formula was
smaller, whereas results of the Hoek and Larsson formulae
underestimated true GFR to a higher degree. Since the true
GFR was, on average, roughly 20 ml/min/1.73 m2 higher than
in our study, the different results may depend on dissimilar
patient characteristics.
Finally, some limitations of our study should be
mentioned: The impact of calibration of the serum creatinine
assay on MDRD estimates has recently been emphasized.21
The Jaffe´ method is known to detect non-creatinine
chromogens also possibly resulting in an overestimation of
creatinine concentration and consecutively in an under-
estimation of creatinine-based GFR estimates. To counteract
this problem we used a kinetic modification of the Jaffe´
method.22 Since we did not used the same MDRD study
system (Beckman CX3) we cannot definitively exclude a
possible bias. However, Hallan et al.21 pointed out that the
bias due to a missing calibration decreases as serum
creatinine level increases. This is crucial since our cohort
comprises a considerably percentage of patients with elevated
creatinine.
Furthermore, the size of our study cohort was small in
comparison to the number of participants of the MDRD
study. However, the different Cys C-based formulae were
derived from cohorts in dissimilar circumstances and
paraphernalia with respect to staff, laboratory work, con-
comitant medication and reference standard clearance. Yet,
these conditions do not facilitate a systemic bias and thus
may rather support our conclusions.
Since our study contained 15 double-transplanted patients it
could be argued that our cohort may be somewhat hetero-
geneous. Nevertheless, analysis of the study group without
these patients did not alter the results (data not shown).
As mentioned above the Cys C-based formulae were
originally tested in cohorts covering a wide range of GFR. In
contrast to those our cohort comprises only patients with a
relatively small range of kidney function. This may affect our
results, especially with respect to the remarkably high
calculated correlation coefficient.
Furthermore, it should be pointed out that all tested
equations in this analysis were derived from studies that used
the identical immunonephelometric assay for Cys C determi-
nation. Since turbidimetric immunoassays tend to produce
higher values, our results may not be transferable to these
assays.23
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Despite these limitations our study shows the diagnostic
equality of Cys C-based equations to the MDRD formula.
Importantly, the Cys C-based Hoek formula was statistically
better than the MDRD equation. However, since the accuracy
within 30 and 50% of true GFR was enhanced merely by
B10% the clinical impact on daily practice remains to be
clarified by further investigations. Nevertheless, we demon-
strate that the recently proposed Cys C-based GFR formulae
are appropriate for calculating GFR in patients after RTx.
Since the overall performance of these formulae are
remarkable even when low-dose prednisone medication
(p5 mg/day) is administered, we conclude that Cys C-based
equations might potentially improve the performance of
prediction of GFR in RTx patients. However, further
confirmation is warranted and currently, a reference method
of GFR determination is required when GFR is an end point
in clinical trials.
MATERIALS AND METHODS
Patients
One hundred and eight consecutive Caucasian patients (45 females,
63 males) with a mean age of 48.9 (95% CI 46.3–51.4) years
underwent 99mTc-DTPA clearance measurements as part of clinical
monitoring in the post-transplant period. This prospective study
was approved by the local Ethics Committee and informed consent
was obtained from all patients enrolled in the study.
The cohort included 12 patients after simultaneous kidney and
pancreas transplantation and three patients after combined liver and
kidney transplantation. 63 patients were treated with cyclosporin A
and 43 patients received tacrolimus. Calcineurin inhibitor treatment
was combined with mycophenolate-mofetil or azathioprine in 47
and three patients, respectively. One patient received sirolimus,
mycophenolate-mofetil and corticosteroids, and another one
sirolimus, tacrolimus and corticosteroids. All participants except
two received corticosteroids. Mean corticosteroid dosage was 6 mg
per day.
Patients included in the study were in ‘steady state’ conditions,
which were defined as lack of increase or decrease of more than 15%
of creatinine within 2 weeks before and after the investigation.
The mean time frame of investigation was 75.4 (95% CI
61.2–87.6) months after transplantation (range 3–240 months; 25
within 12 months after transplantation, 36 one to five years, 16 six
to ten years, and 31 more than 10 years after RTx).
GFR, creatinine, and Cys C measurement
99mTc-DTPA –clearance was performed as single injection technique
with a two point blood sampling according to the method of Russell
et al.24 In contrast to conventional one-compartment models this
method is based on a two-compartment model and known to
prohibit overestimation, which has been shown for one compart-
ment models.24 The results were corrected to the body surface area
which was calculated using the ‘Du Bois formula’.25
Serum creatinine and Cys C were measured from the same
blood samples. Cys C in serum was analyzed by a fully automated
latex-enhanced immunonephelometric method covering the range
of 0.3–8 mg/l (N Latex Cys C Nephelometer II, Dade-Behring,
Marburg, Germany). Serum creatinine was determined on the
DimensionTM clinical chemistry system (Dade-Behring, Marburg,
Germany) with a commercially available assay based on a
modification of the kinetic Jaffe´ reaction reported by Larsen.22
The sensitivities, intrassay, and interassay coefficients of both
methods were as described elsewhere.26
GFR was estimated using the following formulae:
Hoek formula: GFR¼4.32þ 80.35 1/Cys C15
Filler formula: log(GFR)¼ 1.962þ (1.123*log(1/Cys C))27
Larsson formula: GFR¼ 77.239Cys C1.2623 28
Simplified MDRD (MDRD)¼ 186 [serum creatinine (mg/
dl)]1.154 [age]0.203 [0.742 if patient is female] [1.21 if
patient is African-American].8
Statistics
All results are given as mean plus (95% CI). Correlations between
99mTc-DTPA clearance and estimates of GFR were calculated by
linear regression analysis (Pearson’s correlation).
Bias was calculated by the mean difference between the true GFR
(99mTc-DTPA clearance, serving as gold standard) and the estimated
equation-based GFR. Pair-wise comparison of the mean difference
was performed using paired t-test.
The precision of the estimates was expressed in terms of the
RMSE as described elsewhere (RMSE; s.d. of the mean difference
between real GFR and estimated GFR).29
The proportion of GFR estimates within 10, 30, and 50%
deviation of the true GFR served as a measure of accuracy.9
Statistics were carried out using StatViewTM (version 5.0 for
Windows; SAS Institute Inc., Cary, NC, USA). Bland and Altman
analyses of the GFR estimates and the true GFR were performed
with MedcalcTM Software, Mariakerke, Belgium.30 P-values below
0.05 were considered significant.
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